medigraphic.com
ISSN 1527-3172 (Digital)

2017, Número 2-3

<< Anterior Siguiente >>

MEDICC Review 2017; 19 (2-3)


Origin and evolutionary history of HIV-1 subtype B in Cuba

Machado-Zaldívar LY, Díaz-Torres HM, Blanco-de Armas M, Romay-Franchy D, Dubed-Echevarría M

Idioma: Ingles.
Referencias bibliográficas: 46
Paginas: 40-44
Archivo PDF: 169.16 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Worobey M, Gemmel M, Teuwen DE, Haselkorn T, Kunstman K, Bunce M, et al. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature. 2008 Oct 2;455(7213):661–4.

  2. Sharp PM, Hahn BH. The evolution of HIV-1 and the origin of AIDS. Philos Trans R Soc Lond B Biol Sci. 2010 Aug 27;365(1552):2487–94.

  3. Faria NR, Rambaut A, Suchard M, Baele G, Bedford T, Ward MJ, et al. The early spread and epidemic ignition of HIV-1 in human populations. Science. 2014 Oct 3;346(6205):56–61.

  4. Tongo M, Dorfman JR, Martin DP. High degree of HIV-1 group M (HIV-1M) genetic diversity within circulating recombinant forms: insight into the early events of HIV-1M evolution. J Virol. 2015 Dec 9;90(5):2221–9.

  5. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest T, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for AIDS. Science. 1983 May 20;220(4599):868–71.

  6. Montagnier L, Chermann JC, Barr-Sinoussi F. A new human T-lymphotropic retroviruses: characterization and possible role in lymphadenophaty and acquired immunodefi ciency syndromes. In: Gallo RC, Essex ME, Gross L, editors. Human T-cell leukemia/lymphoma virus: the family of human T-lymphotropic retroviruses: their role in malignancies and association with AIDS. New York: Cold Spring Harbor Laboratory Press; 1984. p. 363–79.

  7. Junqueira DM, Almeida SE. HIV-1 subtype B: Traces of a pandemic. Virology. 2016 Aug;495:173–84.

  8. Cabello M, Mendoza Y, Bello G. Spatiotemporal dynamics of dissemination of pandemic HIV-1 subtype B clades in the Caribbean. PLoS One. 2014 Aug 22;9(8):e106045.

  9. Chalmet K, Staelens D, Blot S, Dinakis S, Pelgrom J, Plum J, et al. Epidemiological study of phylogentic transmission clusters in a local HIV- 1 epidemic reveals distinct differences between subtype B and non-B infections. BMC Infect Dis. 2010 Sep 7;10:262.

  10. Magiorkibis G, Angelis K, Mamais I, Katzourakis A, Hatzakis A, Albert J, et al. The global spread of HIV-1 subtype B epidemic. Infect Genet Evol. 2016 Dec 46;169–79.

  11. Rolo F, Miranda L, Wainberg M, Gu Z, Lobaina L, Noa E, et al. Envelope V3 Region Sequences of Cuban HIV-1 Isolates. J Acquir Immune Defi c Syndr Hum Retrovirol. 1995 Jun 1;9(2):123–5.

  12. Gómez C, Iglesias E, Perdomo W, Rolo F, Blanco M, Lobaina L, et al. Isolates from four different HIV type 1 clades circulating in Cuba. Identifi ed by DNA sequence of the C2–V3 region. AIDS Res Hum Retroviruses. 2001 Jan 1;17(1):55–8.

  13. Cuevas MT, Ruibal I, Villahermosa ML, Díaz H, Delgado E, Parga EV, et al. High HIV-1 genetic diversity in Cuba. AIDS. 2002 Aug 16;16(12):1643–53.

  14. Pérez L, Thomson MM, Bleda MJ, Aragonés C, González Z, Pérez J, et al. HIV Type 1 molecular epidemiology in Cuba: high genetic diversity, frequent mosaicism, and recent expansion of BG intersubtype recombinant forms. AIDS Res Hum Retroviruses. 2006 Aug;22(8):724–33.

  15. Machado LY, Blanco M, Dubed M, Díaz HM, Ruiz NM, Valdés N, et al. HIV type 1 genetic diversity in newly diagnosed Cuban patients. AIDS Res Hum Retroviruses. 2012 Aug;28(8):956–60.

  16. Machado LY, Dubed M, Díaz HM, Ruiz NM, Romay D, Valdés N, et al. Transmitted HIV type 1 drug resistance in newly diagnosed Cuban patients. AIDS Res Hum Retroviruses. 2013 Feb;29(2):411–4.

  17. Kourí V, Alemán Y, Pérez L, Pérez J, Fonseca C, Correa C, et al. High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba. J Clin Virol. 2012 Dec;55(4):348–55.

  18. Pérez L, Kourí V, Alemán Y, Abrahantes Y, Correa C, Aragonés C, et al. Antiretroviral drug resistance in HIV-1 therapy-naive patients in Cuba. Infect Genet Evol. 2013 Jun;16:144–50.

  19. Junqueira DM, de Medeiros RM, Matte MC, Araújo LA, Chies JA, Ashton-Prolla P, et al. Reviewing the history of HIV-1: spread of subtype B in the Americas. PLoS One. 2011;6(11):e27489.

  20. Pagán I, Holguín A. Reconstructing the timing and dispersion routes of HIV-1 subtype B epidemics in the Caribbean and Central America: a phylogenetic story. PLoS One. 2013;8(7):e69218.

  21. Delatorre E, Bello G. Phylodynamics of the HIV-1 epidemic in Cuba. PLoS One. 2013 Jul 9;8(7):e72448.

  22. Los Alamos National Laboratory HIV-AIDS Databases [Internet]. New Mexico: Los Alamos National Laboratory; c2005–2017 [cited 2013 Jan 29]. Available from: http://www.hiv.lanl.gov

  23. Hall TA. Bioedit: a user-friendly biological sequence aligment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser. 1999;41:95–8.

  24. Kimura M. A simple method for estimating evolutionary rate of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980 Dec;16(2):111–20.

  25. Tamura KD, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA 5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011 Oct;28(10):2731–9.

  26. Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol. 2012 Aug;29(8):1969–73.

  27. Drummond AJ, Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol. 2007 Nov 8;7:214.

  28. World Medical Association [Internet]. Ferney- Voltaire (FR): World Medical Association; c2017. Helsinki Declaration. Ethical principles for medical research involving human subjects. 59nd General Assembly, Seul, Korea; 2008 Oct [cited 2017 Mar 22]. Available from: https://www.wma .net/policies-post/wma-declaration-of-helsinki -ethical-principles-for-medical-research-invol ving-human-subjects/

  29. Grabowski MK, Redd AD. Molecular tools for studying HIV transmission in sexual networks. Curr Opin HIV AIDS. 2014 Mar;9(2):126–33.

  30. Blanco M, Machado LY, Díaz HM, Ruiz N, Romay D, Silva E. HIV-1 genetic variability in Cuba and implications for transmission and clinical progression. MEDICC Rev. 2015 Oct;17(4):25–31.

  31. Machuca R, Jorgensen LB, Theilade P, Nielsen C. Molecular investigation of transmission of Human Immunodefi ciency Virus type I in a criminal case. Clin Diagn Lab Immunol. 2001 Sep;8(5):884–90.

  32. Gilbert MT, Rambaut A, Wlasiuk G, Spira TJ, Pitchenik AE, et al. The emergence of HIV/AIDS in the Americas and beyond. Proc Natl Acad Sci USA. 2007 Nov 20;104(47):18566-70.

  33. Center for Disease Control (CDC). Pneumocystis carinii pneumonia – Los Angeles. MMWR. 1981 Jun;30(21):250–2.

  34. Buchbinder SP, Katz MH, Hessal NA, O´Malley PM, Holmberg SD. Long term HIV-1 infection without immunologic progression. AIDS. 1994 Aug;8(8):1123–8.

  35. Ruibal-Brunet IJ, Cuevas MT, Díaz-Torres H, Villahermosa ML, Noa-Romero E, Vázquez de Parga E, et al. Genotypic resistance mutations to antiretroviral drugs in HIV-1 B and non-B subtypes from Cuba. Rev Panam Salud Pública. 2001 Sep;10(3):174–80.

  36. Hué S, Clewey JP, Cane PA, Pillay D. HIV-1 pol gene variation is suffi cient for reconstruction of transmissions in the era of antiretroviral therapy. AIDS. 2004 Mar 26;18(5):719–28.

  37. Yebra G, Holguín A, Pillay D, Hué S. Phylogenetic and demographic characterization of HIV-1 transmission in Madrid, Spain. Infect Genet Evol. 2013 Mar;14:232–9.

  38. Pagán I, Holmes EC. Long-term evolution of the Luteoviridae: Time scale and mode of virus speciation. J Virol. 2010 Jun;84(12):6177–87.

  39. Hué S, Pillay D, Clewley JP, Pybus OG. Genetic analysis reveals the complex structure of HIV-1 transmission within defi ned risk groups. Proc Natl Acad Sci USA. 2005 Mar 22;102(12):4425–9.

  40. Hué S, Gifford RJ, Dunn D, Fernhill E, Pillay D; UK Collaborative Group on HIV Drug Resistance. Demonstration of sustained drug-resistant human immunodefi ciency virus type 1 lineages circulating among treatment-naive individuals. J Virol. 2009 Mar;83(6):2645–54.

  41. Salemi M, de Oliveira T, Ciccozzi M, Rezza G, Goodenow MM. High-resolution molecular epidemiology and evolutionary history of HIV-1 subtypes in Albania. PLoS One. 2008 Jan 2;3(1):e1390. DOI: 10.1371/journal. pone.0001390.

  42. Kim GJ, Yun MR, Koo MJ, Shin BG, Lee JS, Kim SS. Estimating the origin an evolution characteristics for Korean HIV type 1 subtype B using Bayesian phylogenetic analysis. AIDS Res Hum Retroviruses. 2012 Aug;28(8):880–4.

  43. Freed EO, Mouland AJ. The cell biology of HIV-1 and other retroviruses. Retrovirology. 2006 Nov 3;3:77.

  44. Nei M, Kumar S. Molecular Evolution and Phylogenetics. Oxford: Oxford University Press; 2000.

  45. Ceccherini-Silberstein F, Gago F, Santoro M, Gori C, Svicher V, Rodríguez-Barrios F, et al. High sequence conservation of human immunodefi ciency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations. J Virol. 2005 Aug;79(16):10718–9.

  46. Santos AFA, Lenbruger RB, Soares EA, Jere A, Sprinz E, Martínez AM, et al. Conservation patterns of HIV-1 RT connection and Rnase H domains: Identifi cation of new mutations in NRTI-treated patients. PLoS One. 2008 Mar 12;3(3):e1781. DOI: 10.1371/journal. pone.0001781.




2020     |     www.medigraphic.com